DENVER, Jan. 26 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. announced today that Dameron Hospital has purchased the SafeTrace Tx(R)* advanced transfusion management system. Terms of the agreements were not disclosed.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO )
The purchase agreement between Wyndgate and Dameron Hospital was developed in close collaboration with Siemens Medical Solutions. With this most recent venture, Wyndgate and Siemens continue to strengthen their ongoing relationship and bring further benefits to their mutual customers.
“There were many considerations in choosing to replace our existing transfusion service system with Wyndgate’s SafeTrace Tx information system,” commented Richard L. Wong CLS, MT (ASCP), Administrative Director of the Clinical Laboratory at Dameron. Mr. Wong continued, “One key consideration was that the system is integrated with Siemens NOVIUS(R) Lab. Another consideration particular to SafeTrace Tx was its Patient-At-A-Glance Bar(TM) safety feature, which displays special transfusion requirements, antibodies, history of transfusion reactions, and the availability of current specimens or autologous donations. Another factor in our decision was Wyndgate’s support of ‘point-of-care’ positive patient identifications systems.”
Wm. Scott Dustin, Vice President of Sales and Marketing for Wyndgate Technologies, said, “Dameron Hospital is committed to high standards for technological superiority and provides its community with quality, advanced healthcare. Wyndgate is pleased that its SafeTrace Tx system will be supporting Dameron’s staff as they uphold these values.” Mr. Dustin also stated, “Our relationship with Siemens continues to grow and prosper. We value all of our partnerships and the benefits they deliver to our customers. We look forward to further collaborations with Siemens in 2006.”
About Dameron Hospital
Dameron Hospital is a fully accredited hospital offering a broad range of medical, surgical, and health maintenance services for emergency and acute care. Both not-for-profit and non-sectarian, Dameron Hospital exists solely to serve the healthcare needs of the community of Stockton, providing its neighbors with advanced technology and state-of-the-art diagnostic and therapeutic equipment -- as well as facilities for inpatient, outpatient and occupational patient care.
About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate’s products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate’s products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R) advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
For more information about Global Med’s products and services, please call 800-WYNDGATE or visit www.globalmedtech.com, www.peoplemed.com and www.wyndgate.com.
This news release may include statements that constitute forward-looking statements, usually containing the words “believe,” “estimate,” “project,” “expects” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
* Patent Pending
Photo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comGlobal Med Technologies, Inc.
CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc.,+1-303-238-2000; or Investor Relations, John Nesbett, or Mike Graff, bothof The Investor Relations Group, +1-212-825-3210, for Global MedTechnologies, Inc.
